Chronopharmaceutics: As a clinically relevant drug delivery system

Drug Delivery

Volumn 18, Issue 1, 2011, Pages 1-18

  Gandhi, B R ^a   Mundada, A S ^a   Gandhi, P P ^b  

^a SSDJ College of Pharmacy   (India)

^b NDMVP Samaj's College of Pharmacy   (India)

Author keywords

Chronopharmaceutics; Circadian rhythms; Lag time control; Pulsed drug release; Time programmed drug release

Indexed keywords

6 CARBOXYFLUORESCEIN; ACETIC ACID; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BIGUANIDE; CALCIUM CHANNEL BLOCKING AGENT; DICLOFENAC; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXORUBICIN; EUDRAGIT; GLUCOCORTICOID; GLUCOSE; GLYCERYL TRINITRATE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYALURONIC ACID; IBUPROFEN; INSULIN; ISOSORBIDE 5 NITRATE; LIPOSOME; MELOXICAM; METHYLPHENIDATE; NONSTEROID ANTIINFLAMMATORY AGENT; POLYMER; SALICYLIC ACID; SODIUM CHLORIDE; SULFONYLUREA; THEOPHYLLINE; UNINDEXED DRUG;

ANGINA PECTORIS; ARTHRITIS; ASTHMA; ATTENTION DEFICIT DISORDER; BIOCOMPATIBILITY; CARDIOVASCULAR DISEASE; CELL DEATH; CHEMICAL STRESS; CHRONOBIOLOGY; CHRONOPHARMACEUTICS; DELAYED DRUG RELEASE; DIABETES MELLITUS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG COATING; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG OVERDOSE; DRUG PELLET; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; ELECTRIC FIELD; ELECTROSTIMULATION; GEL; GLUCOSE BLOOD LEVEL; HUMAN; HYDROGEL; HYDROPHOBICITY; HYPERGLYCEMIA; HYPOGLYCEMIC COMA; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LIPOSOMAL DELIVERY; MAGNETIC FIELD; MEMBRANE PERMEABILITY; MICELLE; NONHUMAN; OSMOTIC PUMP; PARTICULATE MATTER; PEPTIC ULCER; PH MEASUREMENT; PHAGOCYTOSIS; POLYMERIZATION; PRIORITY JOURNAL; PULSATILE DRUG DELIVERY SYSTEM; PULSATILE DRUG RELEASE; REVIEW; RHEUMATOID ARTHRITIS; STOMACH EMPTYING; TABLET FORMULATION; TEMPERATURE; THERMOREGULATION; TIMED DRUG RELEASE; ULTRASOUND;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG CHRONOTHERAPY; DRUG DELIVERY SYSTEMS; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 78650158664     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2010.509358     Document Type: Review

References (76)

1. Babincova, M., Sourivong, P., Chorvát, D., Babinec, P. (1999). Laser triggered drug release from magnetoliposomes. J Magnetism Magn Mater.:163-6.
2. Badve, S.S., Sher, P., Korde, A., Pawar, A.P. (2007). Development of hollow/porous calcium pectinate beads for foating-pulsatile drug delivery. Eur J Pharm Biopharm 65:85-93.
3. Bae, Y.H., Okano, T., Kim, S.W. (1991). 'On-of' thermocontrol of solute transport. I. Temperature dependence of swelling of N-isopropylacrylamide networks modifed with hydrophobic components in water. Pharm Res 8:531-7.
4. Beckert, T.E., Pogarell, K., Hack, I., Petereit, H.U. (1999). Pulsed drug release with flm coatings of Eudragit RS30D. Proceedings of the International Symposium on Controlled Release of Bioactive Materials, Controlled Release Society, Minneapolis, Boston, MA, 5219.
5. Bodmeier, R., Guo, X., Sarabia, R.E., Skultety, P. (1996). Te infu-ence of bufer species and strength on Diltiazem HCl release from beads coated with aqueous cationic polymeric dispersions Eudragit RS, RL30D. Pharm Res 13:52-6.
6. Bussemer, T., Dashevsky, A., Bodmeier, R. (2003a). A pulsatile drug delivery system based on rupturable coated hard gelatin capsules. J Control Release 93:331-9.
7. Bussemer, T., Peppas, N.A., Bodmeier, R. (2003b). Evaluation of the swelling, hydration and rupturing properties of the swelling layer of a rupturable pulsatile drug delivery system. Eur. J Pharm Biopharm 56:261-70.
8. Byl, N.N. (1995). Te use of ultrasound as an enhancer for transcuta-neous drug delivery: phonophoresis. Phys Ter 75:539-53.
9. Chen, C.M. (1993a). Pulsatile particles drug delivery system. US Patent 5,260,069.
10. Chen, C.M. (1993b). Multiparticulate pulsatile drug delivery system. US Patent 5,260,068.
11. Chen, C.M. (1995). Pulsatile particles drug delivery system. US Patent 5,472,708.
12. Chen, H., Langer, R. (1997). Magnetically-responsive polymerized liposomes as potential oral delivery vehicles. Pharm Res 14:537-40.
13. Chen, J., Park, H., Park, K. (1999). Synthesis of superporous hydro-gels: hydrogels with fast swelling and superabsorbent properties. J Biomed Mater Res 44:53-62.
14. Chung, J.E., Yokoyama, M., Okano, T. (2000). Inner core segment design for drug delivery control of thermo-responsive polymeric micelles. J Control Release 65:93-103.
15. Chung, J.E., Yokoyama, M., Yamato, M., Aoyagi, T., Shiino, Y., Sakurai, Y., Okano, T. (1999). Termo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butyl methacrylate). J Control Release 62:115-27.
16. ® ECD. Int J Pharm 318:124-31.
17. Dittigen, M., Fricke, S., Timpe, C., Gercke, H., Eichardt, A. (2000). Method of making a preorally administered solid drug with controlled efective ingredient delivery. US Patent 6, 117,450.
18. Guo, T., Zheng, C.L., Song, H.T., Sui, Y., Dang, D.S., Sun, X.H. (2003). Studies on Diclofenac sodium pulsatile release pellets. Yao Xue Xue Bao 38:707-10.
19. Hartman, P.J.A., Vonk, P., Kossen, N.W.F. (2000). A particulate pulse-release system and mathematical description with the Maxwell-Stefan theory. J Control Release 66:293-306.
20. Hsieh, D.S.T., Langer, R., Folkman, J. (1981). Controlled release of polypeptides and other macromolecules. Proc Natl Acad Sci 78:1863-7.
21. Jimoh, A.G., Wise, D.L., Gresser, J.D., Trantolo, D.J. (1995). Pulsed FSH release from an implantable capsule system. J Control Release 34:87-95.
22. Kadam, V.D., Gattani, S.G. (2009). Formulation and evaluation of a pulsatile drug delivery system using time-and pH-dependant polymers. Pharm Dev Technol 14:27-36.
23. Kaneko, Y., Nakamura, S., Sakai, K., Aoyagi, T., Kikuchi, A., Sakaurai, Y., Okano, T. (1998). Rapid deswelling response of poly (N isopro-pylacrylamide) hydrogels by the formation of water release channels using poly (ethylene oxide) graft chains. Macromolecules 31:6099-105.
24. Kaneko, Y., Sakai, K., Kikuchi, A., Sakurai, Y., Okano, T. (1996). Fast swelling/deswelling kinetics of comb-type grafted poly(N-iso-propylacrylamide) hydrogels. Macromol Chem Macromol Symp 109:41-53. (Pubitemid 126485047)
25. Kaneko, Y., Sakai, K., Kikuchi, A., Yoshida, R., Sakurai, Y., Okano, T. (1995). Infuence of freely mobile grafted chain length on dynamic properties of comb-type grafted poly(N-iso propylacry-lamide) hydrogels. Macromolecules 28:7717-23.
26. Kataoka, K., Harada, A., Nagasaki, Y. (2001). Block copolymer micelles for drug delivery: design, characterization andbiological signif-cance. Adv Drug Deliv Rev 47:113-31.
27. Kataoka, K., Miyazaki, H., Bunya, M., Okano, T., Sakurai, Y. (1998). Totally synthetic polymer gels responding to external glucose concentration: their preparation and application to on-Of regulation of insulin release. J Am Chem Soc 120:12694-5.
28. Kikuchi, A., Okano, T. (2002). Pulsatile drug release control using hydrogels. Adv Drug Deliv Rev 54:53-77.
29. Kim, S.Y., Lee, Y.M. (1999). Drug release behaviour of electrical responsive poly(vinyl alcohol)/poly(acrylic acid) IPN hydrogels under an electric stimulus. J Appl Polym Sci 73:1752-61.
30. Kiser, P., Wilson, G., Needham, D. (2000). Lipid-coated microgels for the triggered release of doxorubicin. J Control Release 68:9-22.
31. Kishi, R., Hirasa, O., Ichijo, H. (1997). Fast responsive poly (N-isopropylacrylamide) hydrogels prepared by g-ray irradiation. Polym Gels Networks 5:145-51.
32. Kohori, F., Sakai, K., Aoyagi, T., Yokoyama, M., Sakurai, Y., Okano, T. (1998). Preparation and characterization of thermally responsive block copolymer micelles comprising poly(N isopropylacrylamide-β-DL-lactide). J Control Release 55:87-98.
33. Kohori, F., Sakai, K., Aoyagi, T., Yokoyama, M., Yamato, M., Sakurai, Y., Okano, T. (1999). Control of adriamycin cytotoxic activity using thermally responsive polymeric micelles com posed of poly(N-isopropylacrylamide-co-N,N- dimethylacrylamide)-β-poly(D,L-lactide), Colloids Surfaces. Biointerfaces 16:195-205.
34. Kost, J. (1993). Ultrasound for controlled delivery of therapeutics. Clin Mater 13:155-61.
35. Krogel, I., Bodmeier, R. (1999). Pulsatile drug delivery system. Int J Pharm 187:175-84.
36. Kwok, C.S., Mourad, P.D., Crum, L.A., Ratner, B.D. (2000). Surface mod-ifcation of polymers with self-assembled molecular structures: multitechnique surface characterization. Biomacromolecules 1:139-48.
37. Kwok, C.S., Mourad, P.D., Crum, L.A., Ratner, B.D. (2001). Self-assembled molecular structures as ultrasonically-responsive barrier membranes for pulsatile drug delivery. J Biomed Mater Res 57:151-64.
38. Langer, R., Igari, Y., Kibat, P.G. (1990). Optimization of a microencap-sulated liposome system for enzymatically controlled release of macromolecules. J Control Release 14:263-7.
39. Lee, D.Y., Chen, C.M. (2000). Delayed pulse release hydrogel matrix tablet. US Patent 6,103,263.
40. Levy, D., Kost, J., Meshulam, Y., Langer, R. (1989). Efect of ultrasound on transdermal drug delivery to rats and guinea pigs. J Clin Invest 83:2074-8.
41. Li, B., Zhu, J., Zheng, C., Gong, W. (2008). A novel system for three-pulse drug release based on "tablets in capsule" device. Int J Pharm 352:159-64.
42. Liu, Y., Liu, S., Dai, Q. (2009). Design and evaluation of pH-independ-ent pulsatile release pellets containing isosorbide-5-mononitrate. Chem Pharm Bull 57:55-60.
43. Machluf, M., Kost, J. (1993). Ultrasonically enhanced transdermal drug delivery. Experimental approaches to elucidate the mechanism. J Biomater Sci Polym 5:147-56.
44. Maloney, J.M., Sbiaa, Z., Santini, J.T., Sheppard, N.F., Uhland, S.A. (2006). Fabrication methods & structures for microreservior devices. US Patent 0, 105,275,A1.
45. Mastiholimath, V.S., Dandagi, P.M., Jain, S.S., Gadad, A.P., Kulkarni, A.R. (2007). Time and pH dependent colon specifc, pulsatile delivery of theophylline for nocturnal asthma. Int J Pharm 328:49-56.
46. Mitragotri, S. (2000). Synergistic efect of enhancers for transdermal drug delivery. Pharm Res 17:1354-9.
47. Mitragotri, S., Blankschtein, D., Langer, R. (1995). Ultrasound-mediated transdermal protein delivery. Science 269:850-3.
48. Mitragotri, S., Blanlschtein, D., Langer, R. (1996). Transdermal drug delivery using low frequency sonophoresis. Pharm Res 13:411-20.
49. Miyata, T., Asami, N., Uragami, T. (1999a). A reversibly antigen responsive hydrogel. Nature 399:766-9.
50. Miyata, T., Asami, N., Uragami, T. (1999b). Preparation of an antigen sensitive hydrogel using antigen-antibody bindings. Macromolecules 32:2082-4.
51. Moriyama, K., Ooya, T., Yui, H. (1999a). Pulsatile peptide release from multi-layered hydrogel formulations consisting of poly-(ethylene glycol)-grafted and ungrafted dextrans. J Biomater Sci Polym 10:1251-64.
52. Moriyama, K., Ooya, T., Yui, N. (1999b). Hyaluronic acid grafted with poly (ethylene glycol) as a novel peptide formulation. J Control Release 59:77-86.
53. Narisawa, S., Nagata, M., Danyoshi, C., Yoshino, H., Murata, K., Hirakawa, Y., Noda, K. (1993). An organic acid induced sigmoi-dal release system for oral controlled release preparation. Pharm Res 11:111-6.
54. Narisawa, S., Nagata, M., Hirakawa, Y., Kobayashi, M., Yoshino, H. (1996). An organic acid induced sigmoidal release system for oral controlled release preparations. 2. Permeability enhancement of Eudragit RS coating led by the physico-chemical interactions with organic acid. J Pharm Sci 85:184-8.
55. Neill, M.E., Rashid, A., Stevens, H.N.E. (1993). Drug dispensing device. GB Patent 2,230,442.
56. Niwa, K., Takaya, T., Morimoto, T., Takada, K. (1995). Preparation and evaluation of a time-controlled release capsule made of ethylcel-lulose for colon delivery of drugs. J Drug Target 3:83-9.
57. Obaidat, A.A., Park, K. (1996). Characterization of glucose dependent gel-sol phase transition of the polymeric glucose-concanavalin A hydrogel system. Pharm Res 13:989-95.
58. Obaidat, A.A., Park, K. (1997). Characterization of protein release, through glucose-sensitive hydrogel membranes. Biomaterials 18:801-6.
59. Okano, T., Bae, Y.H., Jacobs, H., Kim, S.W. (1990). Termally on-of switching polymers for drug permeation and release. J Control Release 11:255-65.
60. Okano, T., Yui, N., Yokoyama, M., Yoshida, R. (1994). Advances in polymeric systems for drug delivery. Gordon and Breach Publisher and Distributor, Yverdon, Switzerland.
61. Rahemba, T.R., Bell, S., Connolly, E., Waterman, K.C. (2009). Use of scoring to induce reproducible drug delivery from osmotic pulsatile tablets. Pharm Dev Technol 14:548-55.
62. Rubinstein, A., Tirosh, B., Baluom, M., Nassar, T., David, A. (1995). Te rationale for peptide drug delivery to the colon and the potential of polymeric carriers as efective tools. J Control Release 46:59-73.
63. Santini, J.T., Cima, M.J., Langer, R.S. (1998). Microchip drug delivery devices. US Patent 5,797,898.
64. Santini, J.T., Cima, M.J., Langer, R.S. (2000). Fabrication of microchip drug delivery devices. US Patent 6,123,861.
65. Schellekens, R.C.A., Stellaard, F., Mitrovic, D., Stuurman, F.E., Kosterink, J.G.W., Frijlink, H.W. (2008). Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disin-tegrants in pH-responsive polymer coatings. J Control Release 132:91-8.
66. Sharma, S., Pawar, A. (2006). Low density multiparticulate system for pulsatile release of Meloxicam. Int J Pharm 313:150-8.
67. Sher, P., Ingavle, G., Ponrathnam, S., Pawar, A.P. (2007). Low density porous carrier based conceptual drug delivery system. Microporous Mesoporous Mater 102:290-8.
68. Shivakumar, H.N., Suresh, S., Desai, B.G. (2006). Design and evaluation of pH sensitive multi-particulate systems for chronotherapeutic delivery of diltiazem hydrochloride. Ind J Pharm Sci 68:781-7.
69. Ueda, S., Hata, T., Yamaguchi, H., Kotani, M., Ueda, Y. (1994a). Development of a novel drug release system, timecontrolled explosion system (TES): I. Concept and design. J Drug Target 2:35-44. (Pubitemid 24106958)
70. Ueda, S., Yamaguchi, H., Kotani, M., Kimura, S., Tokunaga, Y., Kagayama, A., Hata, T. (1994b). Development of a novel drug release system, time-controlled explosion system (TES): II. Design of multiparticulate TES and in vitro drug release properties. Chem Pharm Bull 42:359-63.
71. Ueda, S., Yamaguchi, H., Kotani, M., Kimura, S., Tokunaga, Y., Kagayama, A., Hata, T. (1994c). Development of a novel drug release system, time-controlled explosion system (TES): III. Relation between lag time and membrane thickness. Chem Pharm Bull 42:364-7.
72. Ueda, Y., Hata, T., Hisami, Y., Ueda, S., Kodani, M. (1989). Time controlled explosion systems and process for preparing the same. US Patent 4, 871,549.
73. Yoshida, R., Uchida, K., Kaneko, Y., Sakai, K., Kikuchi, A., Sakurai, Y., Okano, T. (1995). Comb-type grafted hydrogels with rapid temperature responses. Nature 374:240-2.
74. Yui, N., Nihira, J., Okano, T., Sakurai, Y. (1993). Regulated release of drug microspheres from infammation responsive degrada-ble matrices of crosslinked hyaluronic acid. J Control Release 25:133-43.
75. Yui, N., Okano, T., Sakurai, Y. (1992). Infammation responsive degradation of crosslinked hyaluronic acid gels. J Control Release 22:105-16.
76. Yuk, S.H., Cho, S.H., Lee, H.B. (1992). Electric current-sensitive drug delivery systems using sodium-alginate/polyacrylic acid composites. Pharm Res:955-7.